Impact of Body Mass Index on Short-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention in Newfoundland and Labrador, Canada
Table 1
Baseline characteristics of patients according to categories of BMI.
Variable
Total
NW
OW
OB
valu
Number of patients
6473
1073
2608
2792
Age, years
6473
Male sex
6473
695 (64.8)
1975 (75.7)
1945 (69.7)
Cardiovascular risk factors
HTN
6462
658 (61.4)
1661 (63.8)
2066 (74.1)
Hyperlipidemia
6462
905 (84.4)
2241 (86.1)
2434 (87.4)
Diabetes
6464
226 (21.1)
637 (24.5)
1040 (37.3)
Family history
6440
622 (58.3)
1627 (62.7)
1822 (65.5)
Smoking status
6421
Never
1719
298 (28.1)
698 (27.0)
723 (26.1)
Smoking history
4702
763 (71.9)
1891 (73.0)
2048 (73.9)
PVD
6460
91 (8.5)
172 (6.6)
156 (5.6)
COPD
6459
156 (14.6)
335 (12.9)
479 (17.2)
Values are presented as (%) or mean ± SD, as indicated. values for chi-squared or ANOVA tests. BMI: body mass index; COPD: chronic obstructive pulmonary disease; NW: normal weight; OB: obese; OW: overweight; HTN: hypertension; PVD: peripheral vascular disease.
